PAND · Pandion Therapeutics
Acquired Company
Merck completed the acquisition of Pandion Therapeutics on 4/1/2021 for $60 per share in cash, representing an approximate total equity value of $1.85 billion.
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$60.05
Open
$60.05
Volume
N/A
Day Range
$60.05 - $60.05
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Sep 30th 2024